Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.84 USD | +1.54% | +4.50% | +30.44% |
09/04 | Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating | MT |
08/04 | Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.44% | 4.77B | |
+25.88% | 661B | |
+26.79% | 566B | |
-6.37% | 352B | |
+20.54% | 332B | |
+3.57% | 283B | |
+14.15% | 231B | |
+5.14% | 200B | |
-8.96% | 195B | |
-4.98% | 145B |
- Stock Market
- Equities
- OGN Stock
- News Organon & Co.
- Goldman Sachs Adjusts Price Target for Organon & Co to $41 From $42, Maintains Buy Rating